Home › Funds › Two Sigma Investments › LCTX
Two Sigma Investments position in LCTX
LINEAGE CELL THERAPEUTICS IN · Health Care
Latest position (Q2 2026)54.95K sh
Reported value held$71.98K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 580.79K | $1.46M | New |
| Q4 2021 | 540.82K | $1.32M | Reduce |
| Q4 2022 | 30.66K | $35.88K | New |
| Q1 2023 | 25.31K | $37.96K | Reduce |
| Q2 2023 | 81.82K | $115.36K | Add |
| Q4 2024 | 301.54K | $151.53K | New |
| Q1 2025 | 480.42K | $216.96K | Add |
| Q2 2025 | 317.98K | $288.53K | Reduce |
| Q3 2025 | 354.35K | $598.85K | Add |
| Q4 2025 | 265.58K | $443.53K | Reduce |
| Q1 2026 | 88.58K | $139.96K | Reduce |
| Q2 2026 | 54.95K | $71.98K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding LCTX
- BlackRock Inc 13.19M sh · $17.27M · Q2 2026
- Vanguard Group 9.64M sh · $16.11M · Q4 2025
- Geode Capital Management 5.30M sh · $6.94M · Q2 2026
- Millennium Management 3.02M sh · $3.95M · Q2 2026
- Northern Trust Corp 1.66M sh · $2.17M · Q2 2026
- Morgan Stanley 1.47M sh · $1.93M · Q2 2026
- Renaissance Technologies 1.34M sh · $1.76M · Q2 2026
- Marshall Wace 1.28M sh · $1.68M · Q2 2026
- UBS Group AG 687.05K sh · $900.04K · Q2 2026
- Charles Schwab Investment Management 577.43K sh · $756.44K · Q2 2026
- Citadel Advisors 465.57K sh · $609.90K · Q2 2026
- Goldman Sachs Group 433.27K sh · $567.58K · Q2 2026